Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 19 hours 22 min ago

FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies

Fri, 04/19/2024 - 02:00
FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies 4/19/2024

Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC

Fri, 04/19/2024 - 02:00
Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC 4/19/2024

Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring

Fri, 04/19/2024 - 02:00
Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring 4/19/2024

J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations?

Fri, 04/19/2024 - 02:00
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations? 4/19/2024

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies

Fri, 04/19/2024 - 02:00
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies 4/19/2024

Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market

Thu, 04/18/2024 - 02:00
Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market 4/18/2024

Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win

Thu, 04/18/2024 - 02:00
Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win 4/18/2024

Cerevel Gets Phase III Parkinson’s Win on Heels of $8.7B AbbVie Acquisition

Thu, 04/18/2024 - 02:00
Cerevel Gets Phase III Parkinson’s Win on Heels of $8.7B AbbVie Acquisition 4/18/2024

Most Doses of Lilly’s Zepbound and Mounjaro in Short Supply Through Q2: FDA

Thu, 04/18/2024 - 02:00
Most Doses of Lilly’s Zepbound and Mounjaro in Short Supply Through Q2: FDA 4/18/2024

Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch

Thu, 04/18/2024 - 02:00
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch 4/18/2024

Roche’s Ocrevus Achieves Near-Complete Reduction of Relapse, Lesions in MS

Thu, 04/18/2024 - 02:00
Roche’s Ocrevus Achieves Near-Complete Reduction of Relapse, Lesions in MS 4/18/2024

Bioversity Program Preps Grads for Early-Career Life Science Roles

Thu, 04/18/2024 - 02:00
Bioversity Program Preps Grads for Early-Career Life Science Roles 4/18/2024

How to Deal With Layoff-Related Stress

Thu, 04/18/2024 - 02:00
How to Deal With Layoff-Related Stress 4/18/2024

Career Coach: How to Look Professional in Virtual Meetings

Thu, 04/18/2024 - 02:00
Career Coach: How to Look Professional in Virtual Meetings 4/18/2024

5 Top Companies Hiring Oncology Jobs

Thu, 04/18/2024 - 02:00
5 Top Companies Hiring Oncology Jobs 4/18/2024

Lilly Eyes Zepbound Label Expansion After Clearing Phase III Sleep Apnea Study

Wed, 04/17/2024 - 02:00
Lilly Eyes Zepbound Label Expansion After Clearing Phase III Sleep Apnea Study 4/17/2024

Sage Axes Parkinson’s Program for Dalzanemdor After Phase II Flop

Wed, 04/17/2024 - 02:00
Sage Axes Parkinson’s Program for Dalzanemdor After Phase II Flop 4/17/2024

Amylyx Sheds More Light on Relyvrio’s Late-Stage Trial Failure in ALS

Wed, 04/17/2024 - 02:00
Amylyx Sheds More Light on Relyvrio’s Late-Stage Trial Failure in ALS 4/17/2024

Amylyx at a Crossroads: Can the Company Overcome the Loss of Relyvrio?

Wed, 04/17/2024 - 02:00
Amylyx at a Crossroads: Can the Company Overcome the Loss of Relyvrio? 4/17/2024

Arvinas Strikes Deals With Pfizer, Novartis to Compete in Protein Degrader Space

Wed, 04/17/2024 - 02:00
Arvinas Strikes Deals With Pfizer, Novartis to Compete in Protein Degrader Space 4/17/2024